Jason Beaubien

Jason Beaubien is NPR's Global Health and Development Correspondent on the Science Desk.

In this role, he reports on a range of health issues across the world including the mobilization of massive circumcision drives in Kenya; how Botswana, with one of the highest rates of HIV in the world, has managed to provide free, life-saving drugs to almost all who need them; and why Brazil's once model HIV/AIDS program is seen in decline.

Prior to moving into this assignment in 2012, Beaubien spent four years a NPR foreign correspondent covering Mexico, Central America and the Caribbean. From his base in Mexico City, Beaubien filed stories on politics in Cuba, hurricanes in Haiti, the FMLN victory in El Salvador, the world's richest man and Mexico's brutal drug war.

For his first multi-part series as the Mexico City correspondent, Beaubien drove the length of the U.S./Mexico border making a point to touch his toes in both oceans. The stories chronicled the economic, social and political changes along the violent frontier.

In 2002, Beaubien joined NPR after volunteering to cover a coup attempt in the Ivory Coast. Over the next four years, Beaubien worked as a foreign correspondent in sub-Saharan Africa, visiting 27 countries on the continent. His reporting ranged from poverty on the world's poorest continent, the HIV in the epicenter of the epidemic, and the all-night a cappella contests in South Africa, to Afro-pop stars in Nigeria and a trial of white mercenaries in Equatorial Guinea.

During this time, he covered the famines and wars of Africa, as well as the inspiring preachers and Nobel laureates. Beaubien was one of the first journalists to report on the huge exodus of people out of Sudan's Darfur region into Chad, as villagers fled some of the initial attacks by the Janjawid. He reported extensively on the steady deterioration of Zimbabwe and still has a collection of worthless Zimbabwean currency.

In 2006, Beaubien was awarded a Knight-Wallace fellowship at the University of Michigan to study the relationship between the developed and the developing world.

Beaubien grew up in Maine, started his radio career as an intern at NPR Member Station KQED in San Francisco and worked at WBUR in Boston before joining NPR.

Pages

Science
5:17 pm
Wed April 10, 2013

Synthetic Malarial Drug Ingredient Could Cut Cost Of Treatment

Scientists have come up with a new way to produce the most common anti-malaria medicine currently on the market and a French pharmaceutical company is opening a new plant this week to manufacture it. The synthetic version of artemisinin is expected to stabilize the malaria medicine market and reduce the overall cost of malaria treatment.

Shots - Health News
10:33 am
Mon April 8, 2013

Dengue Fever Cases Have Been Seriously Underestimated

Dengue fever patients are treated in a hospital in Asuncion, Paraguay, in January.
Norberto Duarte AFP/Getty Images

Originally published on Mon April 8, 2013 10:38 am

A new paper in the journal Nature says scientists have been seriously underestimating the amount of dengue around the globe.

The study says there could be as many as 400 million dengue infections worldwide each year making it more prevalent than malaria. This is four times higher than the current dengue prevalence estimate of the World Health Organization.

Read more
Shots - Health News
5:20 pm
Tue April 2, 2013

How To Get Rid Of Polio For Good? There's A $5 Billion Plan

A child is immunized against polio at the health clinic in a farming village in northern Nigeria. The procedure involves pinching two drops of the vaccine into the child's mouth. For full protection, the child needs three doses, spaced out over time.
David Gilkey NPR

Originally published on Tue April 2, 2013 8:56 pm

Polio is on the verge of being eliminated. Last year there were just over 200 cases of polio, and they occurred in just two remote parts of the world — northern Nigeria and the rugged Afghan-Pakistan border region.

A new $5.5 billion plan being pushed by the World Health Organization strives to eliminate polio entirely, phase out vaccination campaigns and secure polio vaccine stockpiles in case the virus somehow manages to re-emerge.

If the effort is successful, polio would be just the second disease in human history, after smallpox, to be eliminated by medical science.

Read more

Pages